27
Participants
Start Date
June 3, 2021
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2026
Ultrafractionated radiotherapy for rectal cancer
To determine the toxicity of dose-escalated hypofractionated RT, in patients with locally advanced rectal cancer treated with RT, FOLFOX or CAPOX chemotherapy and selective omission of surgery.
RECRUITING
UT Southwestern Medical Center, Dallas
University of Texas Southwestern Medical Center
OTHER